The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Karyopharm Therapeutics
Stock and Other Ownership Interests - Karyopharm Therapeutics
Patents, Royalties, Other Intellectual Property - Karyopharm Therapeutics
Digital monitoring and assessments in patients with glioblastoma.
 
Yasaman Damestani
Employment - Karyopharm Therapeutics
 
Ruiyang Shi
Employment - Karyopharm Therapeutics
 
Kai Li
Employment - Karyopharm Therapeutics
 
Patrice Melikian
Employment - Karyopharm Therapeutics
 
Shelley Haybeck
Employment - Karyopharm Therapeutics
 
Gregory Mundy
Employment - Karyopharm Therapeutics
 
Gursharan Gill
Employment - Karyopharm Therapeutics
 
Shijie Tang
Employment - Karyopharm Therapeutics
 
Eric Sbar
Employment - Karyopharm Therapeutics
 
Tracey Duncan
Employment - Karyopharm Therapeutics
 
Sharon Tamir
Employment - Karyopharm Therapeutics
 
Eran Shacham
Employment - Karyopharm Therapeutics
 
Jatin J. Shah
Employment - Karyopharm Therapeutics
Stock and Other Ownership Interests - Karyopharm Therapeutics
 
Sharon Shacham
No Relationships to Disclose
 
Patrick Y. Wen
Consulting or Advisory Role - Agios; AstraZeneca; Bayer; Black Diamond Therapeutics; Blue Earth Diagnostics; Boston Pharmaceuticals; Celularity; Chimerix; Day One Biopharmaceuticals; ElevateBio; Imvax; Integral Health; Karyopharm Therapeutics; Merck; Mundipharma; Novartis; Novocure; Nuvation Bio; Prelude Therapeutics; QED Therapeutics; Sapience Therapeutics; Tocagen; Vascular Biogenics; VBI Vaccines; Voyager Therapeutics
Research Funding - Agios (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Bayer (Inst); Beigene (Inst); Celgene (Inst); Chimerix (Inst); Karyopharm Therapeutics (Inst); Kazia Therapeutics (Inst); Lilly (Inst); MediciNova (Inst); Merck (Inst); Novartis (Inst); Nuvation Bio (Inst); Oncoceutics (Inst); Puma Biotechnology (Inst); Vascular Biogenics (Inst); VBI Vaccines (Inst)
 
Erin Dunbar
No Relationships to Disclose
 
Priya Kumthekar
Stock and Other Ownership Interests - EnClear Therapies; Vivacitas Oncology
Consulting or Advisory Role - Affinia Therapeutics; Biocept; BioClinica; ElevateBio; EnClear Therapies; Janssen; Novocure; Orbus Therapeutics; SDP Oncology; Sintetica
Research Funding - Angiochem; DNAtrix; Genentech; Novocure; Orbus Therapeutics
Patents, Royalties, Other Intellectual Property - Utility patent for ANG 1005. No financial gain, no royalties.
 
Howard Colman
Consulting or Advisory Role - Abbvie; Adastra Pharmaceuticals; Adastra Pharmaceuticals; Bayer; Best Doctors, Inc; FORMA Therapeutics; Karyopharm Therapeutics; Newlink Genetics; Orbus Therapeutics; Private Health
Research Funding - Abbvie (Inst); Array BioPharma (Inst); Bayer; BeiGene (Inst); Bristol-Myers Squibb; DNAtrix (Inst); FORMA Therapeutics (Inst); Global Coalition for Adaptive Research (Inst); Kadmon (Inst); Merck (Inst); Newlink Genetics (Inst); Nuvation Bio; Orbus Therapeutics (Inst); Plexxikon (Inst)
Travel, Accommodations, Expenses - Bayer; FORMA Therapeutics; Karyopharm Therapeutics; Orbus Therapeutics
 
Robert Aiken
Stock and Other Ownership Interests - Johnson & Johnson; Northwest Biotherapeutics
Honoraria - Tactical Therapeutics
Consulting or Advisory Role - Gerson Lehrman Group; Guidepoint Inc
Research Funding - CNS Pharmaceuticals (Inst); Gan & Lee (Inst); Karyopharm Therapeutics (Inst); MimiVax (Inst); Nuvation Bio (Inst)
Patents, Royalties, Other Intellectual Property - Axl1717
 
Nicholas A. Butowski
Stock and Other Ownership Interests - Cordance; Cordance
Consulting or Advisory Role - Cellinta; DelMar Pharmaceuticals; Gan & Lee; Karyopharm Therapeutics; KIYATEC; Lynx Group; Plus Therapeutics; QED Therapeutics; Sagimet Biosciences; Tocagen; VBI Vaccines; VBL Therapeutics
Research Funding - Abbvie (Inst); Amgen; Amgen (Inst); Arbor Pharmaceuticals (Inst); BeiGene (Inst); BeiGene (Inst); BioMimetix (Inst); Bristol-Myers Squibb (Inst); Deciphera (Inst); EpicentRx; Five Prime Therapeutics; Ipsen; Istari (Inst); KIYATEC (Inst); Medicenna; Merck; Oncoceutics (Inst); Orbus Therapeutics; Tocagen (Inst)